YS

Yingxia Sang

GL Glaxo Group Limited: 2 patents #493 of 1,368Top 40%
IC Inxmed (Nanjing) Co.: 1 patents #5 of 12Top 45%
Overall (All Time): #546,035 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
11999719 Solid form of compound Zaiqi Wang, Jing Gao 2024-06-04
11034696 Compounds for inhibiting LRRK2 kinase activity Feng Ren, Weiqiang XING, Yang Zhan, Baowei Zhao 2021-06-15
10975081 Substituted fused pyrazole compounds and their use as LRRK2 inhibitors Xiao Ding, Yun Jin, Qian Liu, Feng Ren, Luigi Piero Stasi +5 more 2021-04-13
10858367 Compounds Xiao Ding, Feng Ren, Weiqiang XING, Yang Zhan, Baowei Zhao 2020-12-08
10618901 LRRK2 inhibitors for the treatment of Parkinson's disease Xiao Ding, Qian Liu, Luigi Piero Stasi, Zehong Wan, Baowei Zhao +1 more 2020-04-14
9815841 Compounds Xiao Ding, Qian Liu, Kai Long, Luigi Piero Stasi, Zehong Wan +2 more 2017-11-14
9708330 2,3-dihydroimidazol[1,2-C]pyrimidin-5(1-H)-one based ipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitors Zehong Wan, Qing Zhang 2017-07-18
9051325 Bicyclic [5,6] imidazo pyrimodone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2 Zehong Wan, Qing Zhang 2015-06-09
8975400 2,3-dihydroimidazo[1, 2-c] pyrimidin-5(1 H)-one compounds use as LP-PLA2 inhibitors Zehong Wan, Kai Long, Xiaobo Su 2015-03-10